Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 12Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Non-Hodgkin 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Lymphoma, Large-Cell, Anaplastic 3Burkitt Lymphoma 3Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Cardiotoxicity 1

Interventions

liposomal amphotericin B 2Rituximab 2Levofloxacin 2Gemcitabine 2Early Intervention, Educational 2Doxorubicin 2Darbepoetin alfa 2ferrous sulfate 1ferric gluconate 1duvelisib 1belinostat 1Vincristine 1VAP-cyclo protocol 1Sucrose 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Pharmacogenomic Testing 1Ondansetron 1Morphine 1Ketamine 1Hypericum extract LI 160 1Filgrastim 1Fentanyl 1Epoetin Alfa 1Drug Therapy 1Dextromethorphan 1Dexamethasone 1Dalteparin 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Immunoblastic Lymphadenopathy × VAP-cyclo protocol × Clear all
NCT00052936 2021-05-18

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Universität des Saarlandes

Phase 3 Completed
1,506 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡